Related Experiment Video
Updated: Nov 5, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
SynLeGG: analysis and visualization of multiomics data for discovery of cancer 'Achilles Heels' and gene function
Mark Wappett1,2, Adam Harris1, Alexander L R Lubbock3
1Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast BT9 7AE, UK.
Abstract:
Achilles' heel relationships arise when the status of one gene exposes a cell's vulnerability to perturbation of a second gene, such as chemical inhibition, providing therapeutic opportunities for precision oncology. SynLeGG (www.overton-lab.uk/synlegg) identifies and visualizes mutually exclusive loss signatures in 'omics data to enable discovery of genetic dependency relationships (GDRs) across 783 cancer cell lines and 30 tissues. While there is significant focus on genetic approaches, transcriptome data has advantages for investigation of GDRs and remains relatively underexplored. SynLeGG depends upon the MultiSEp algorithm for unsupervised assignment of cell lines into gene expression clusters, which provide the basis for analysis of CRISPR scores and mutational status in order to propose candidate GDRs. Benchmarking against SynLethDB demonstrates favourable performance for MultiSEp against competing approaches, finding significantly higher area under the Receiver Operator Characteristic curve and between 2.8-fold to 8.5-fold greater coverage. In addition to pan-cancer analysis, SynLeGG offers investigation of tissue-specific GDRs and recovers established relationships, including synthetic lethality for SMARCA2 with SMARCA4. Proteomics, Gene Ontology, protein-protein interactions and paralogue information are provided to assist interpretation and candidate drug target prioritization. SynLeGG predictions are significantly enriched in dependencies validated by a recently published CRISPR screen.
Insights
SynLeGG identifies genetic dependency relationships (GDRs) by analyzing gene expression data, uncovering Achilles' heel vulnerabilities for precision cancer therapy. This approach enhances the discovery of synthetic lethality across diverse cancer cell lines and tissues.
Area of Science:
- Genomics
- Computational Biology
- Cancer Research
Background:
- Achilles' heel relationships, where one gene's status sensitizes cells to another's perturbation, offer therapeutic targets in precision oncology.
- Investigating genetic dependency relationships (GDRs) using transcriptome data is underexplored despite its advantages over genetic approaches.
Purpose of the Study:
- To introduce SynLeGG, a tool for identifying and visualizing mutually exclusive loss signatures in omics data to discover GDRs.
- To leverage transcriptome data for uncovering novel GDRs and tissue-specific vulnerabilities.
Main Methods:
- SynLeGG utilizes the MultiSEp algorithm for unsupervised clustering of cell lines based on gene expression.
- Analysis involves correlating CRISPR scores and mutational status within identified clusters to propose candidate GDRs.
- Benchmarking against SynLethDB assessed MultiSEp's performance using Receiver Operator Characteristic curves and coverage.
Main Results:
- MultiSEp demonstrated superior performance compared to competing methods, achieving significantly higher area under the ROC curve and 2.8- to 8.5-fold greater coverage.
- SynLeGG successfully identified pan-cancer and tissue-specific GDRs, including the known synthetic lethality of SMARCA2 with SMARCA4.
- Predictions from SynLeGG were significantly enriched in dependencies validated by recent CRISPR screens.
Conclusions:
- SynLeGG provides a robust platform for discovering genetic dependency relationships using transcriptome data.
- The tool aids in prioritizing potential drug targets by integrating multi-omics information and identifying vulnerabilities exploitable in cancer therapy.
More Related Videos
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Related Concept Videos
Genomics
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...